
### [NCIT:C2879](http://purl.obolibrary.org/obo/NCIT_C2879)
**Label:** Neoplasm of the Diffuse Neuroendocrine System

**Subclasses:** [NCIT:C4216](http://purl.obolibrary.org/obo/NCIT_C4216) (Sympathetic Paraganglioma), [NCIT:C5328](http://purl.obolibrary.org/obo/NCIT_C5328) (Extra-Adrenal Retroperitoneal Paraganglioma), [NCIT:C6416](http://purl.obolibrary.org/obo/NCIT_C6416) (Malignant Bladder Paraganglioma), [NCIT:C27279](http://purl.obolibrary.org/obo/NCIT_C27279) (Localized Adrenal Gland Pheochromocytoma), [NCIT:C48576](http://purl.obolibrary.org/obo/NCIT_C48576) (Extra-Adrenal Sympathetic Paraganglioma), [NCIT:C3326](http://purl.obolibrary.org/obo/NCIT_C3326) (Adrenal Gland Pheochromocytoma), [NCIT:C6414](http://purl.obolibrary.org/obo/NCIT_C6414) (Bladder Paraganglioma), [NCIT:C4220](http://purl.obolibrary.org/obo/NCIT_C4220) (Malignant Adrenal Gland Pheochromocytoma), [NCIT:C48305](http://purl.obolibrary.org/obo/NCIT_C48305) (Benign Adrenal Gland Pheochromocytoma), [NCIT:C8047](http://purl.obolibrary.org/obo/NCIT_C8047) (Recurrent Adrenal Gland Pheochromocytoma), [NCIT:C8045](http://purl.obolibrary.org/obo/NCIT_C8045) (Regional Adrenal Gland Pheochromocytoma), [NCIT:C92184](http://purl.obolibrary.org/obo/NCIT_C92184) (Malignant Adrenal Gland Composite Pheochromocytoma), [NCIT:C8046](http://purl.obolibrary.org/obo/NCIT_C8046) (Metastatic Adrenal Gland Pheochromocytoma), [NCIT:C48306](http://purl.obolibrary.org/obo/NCIT_C48306) (Adrenal Gland Composite Pheochromocytoma), [NCIT:C92181](http://purl.obolibrary.org/obo/NCIT_C92181) (Benign Adrenal Gland Composite Pheochromocytoma), [NCIT:C118822](http://purl.obolibrary.org/obo/NCIT_C118822) (Childhood Adrenal Gland Pheochromocytoma), 

**Class expressions from DL-Learner:**

- [NCIT:C43574](http://purl.obolibrary.org/obo/NCIT_C43574) (Neuroendocrine Differentiation) 55.56%
- Thing 52.40%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 40.91%


